ENVALITH
株式会社ソフィアホールディングス logo

SOPHIA HOLDINGS CO.,LTD.

6942Standard MarketInformation & Communication

株式会社ソフィアホールディングス logo
SOPHIA HOLDINGS CO.,LTD.6942

Business

Sophia Holdings Co., Ltd. is a TSE Standard-listed pure holding company overseeing 8 consolidated subsidiaries. Centered on its Dispensing Pharmacy and Related Business (operating 60 stores), which accounts for approximately 84% of revenue, the group consists of three segments: this core business, the Internet-Related Business (IT engineer dispatch and system development), and the Telecommunications Business (centered on MVNO). Consolidated revenue for FY2026 (ending March 2026) was ¥8,329 million. The company entered the dispensing pharmacy business through a business alliance with its parent company, E-BOND Holdings, and positions group synergies from the fusion of ICT and healthcare as a pillar of its medium- to long-term strategy.

Business Model

The majority of revenue consists of medical service fee and drug price income from prescription dispensing and pharmaceutical sales at dispensing pharmacies. In the Internet-Related Business, the company earns recurring service revenue through System Engineering Dispatch Services (SES Business) and contracted system development. The Telecommunications Business generates revenue from reselling MVNO lines and providing corporate solutions. Expanding the store and engineer base through M&A, along with cost reductions and service enhancement through group-wide synergies, serve as means of improving profitability.

Company Strengths

Through repeated M&A and business acquisitions, the company operated 60 dispensing pharmacy stores as of the end of FY2026 (ending March 2026). Revenue reached ¥6,972 million (up 0.4% year on year) and segment profit reached ¥363 million (up 75.7% year on year), forming a stable foundation for group revenue. The number of patients visiting continues to increase, and the community-based store network underpins revenue.

The company holds three segments—Dispensing Pharmacy and Related Business, IT engineer dispatch and system development, and MVNO Services—thereby diversifying single-industry risk. In FY2026 (ending March 2026), the Internet-Related Business achieved a segment profit margin of 5.7%, and the Telecommunications Business turned profitable (segment profit of ¥27 million), with each business functioning as an independent revenue source.

Since 2018, the company has acquired and integrated multiple pharmacy chains in the Dispensing Pharmacy and Related Business, building a 60-store network. In October 2025, it made Sophia Security Co., Ltd. (formerly Security Agent Co., Ltd.) a subsidiary, expanding the scope of the Internet-Related Business. The company's ability to execute business expansion through M&A can be confirmed in the corporate history section of its securities report.

ENVALITH's Perspective

In FY2026 (ending March 2026), the dispensing pharmacy segment profit was strong at ¥363 million (up 75.7% year on year), while the companywide operating loss fell to ¥60 million. Against total segment profit of ¥457 million, the adjustment amount (companywide expenses, etc.) was a negative ¥503 million, clearly illustrating a structure in which the heavy burden of holding company costs is squeezing profitability. Reducing and streamlining companywide expenses is key to returning to profitability, and a substantial improvement in the adjustment amount is essential to achieving the FY2027 (ending March 2027) forecast operating profit of ¥159 million.

The company forecasts revenue of ¥8,928 million (up 7.2% year on year), operating profit of ¥159 million, and net profit of ¥7 million for FY2027 (ending March 2027). This represents a scenario of rapid recovery from the operating loss of ¥60 million in the previous period, but uncertainties remain high, including continued headwinds from dispensing fee and drug price revisions, intensifying MVNO competition, and the extent to which the holding company cost structure can be improved. In addition, an impairment loss of ¥230 million was recorded again in the current period, and continued monitoring is needed of the risk of further impairment against the goodwill balance of ¥1,838 million.

Cash and cash equivalents at the end of FY2026 (ending March 2026) decreased by ¥602 million year on year to ¥2,145 million. Operating cash flow was nearly halved to ¥128 million (from ¥261 million in the previous period), weighed down by corporate tax payments of ¥328 million. The cash flow to interest-bearing debt ratio worsened from 8.9 years to 16.3 years, and the interest coverage ratio also declined from 10.7 times to 5.7 times. Investment activity also continued, including ¥144 million in expenditure for business acquisitions, and if the negative trend in free cash flow persists, attention should be paid to the depletion of financial flexibility.

Growth Strategy

Expansion of dispensing pharmacy stores and profitability improvement, combined with ICT × healthcare integration to create group synergies

Continuing to expand the store network through business acquisitions (¥144 million spent in FY2026 (ending March 2026)). Building on the 60-store base as of the end of FY2026 (ending March 2026), the company will pursue new store openings and acquisitions while weighing capital efficiency and earnings contribution, aiming to improve profitability through scale merits.

Continuing to review operations across 60 stores and rationalize unprofitable stores to compress selling, general and administrative expenses. In FY2026 (ending March 2026), the Dispensing Pharmacy and Related Business segment profit improved significantly to ¥363 million (up 75.7% year on year), reflecting the effects of these measures.

Expanding the scope of the ICT business through active M&A, including making Security Agent a subsidiary. Also focusing on recruiting and developing engineers skilled in generative AI, cloud development, and infrastructure construction, aiming to expand revenue by capturing DX demand.

In the Telecommunications Business, revenue reached ¥228 million (up 49.4% year on year) with a segment profit of ¥27 million in FY2026 (ending March 2026), turning profitable. The company will continue to drive revenue and profit growth in the MVNO business by strengthening sales of its in-house developed Customer Order Systems and launching new businesses.

In FY2026 (ending March 2026), company-wide adjustment (expenses) of ¥503 million exceeded the total segment profit of ¥457 million, becoming the main cause of the operating loss. Achieving the forecast operating profit of ¥159 million in FY2027 (ending March 2026) requires substantial reduction of company-wide expenses, making efficiency improvements in group management costs an urgent priority.

Last updated: July 19, 2026